Clinical Study

Mortality and Recovery of Renal Function in Acute Kidney Injury Patients Treated with Prolonged Intermittent Hemodialysis Sessions Lasting 10 versus 6 Hours: Results of a Randomized Clinical Trial

Table 4

Metabolic and volume control of the studied groups in the first three sessions of PHD.

G1 = 6 h (n = sessions)G2 = 10 h (n = sessions)
S1
(n = 104)
S2
(n = 70)
S3
(n = 38)
S1
(n = 90)
S2
(n = 63)
S3
(n = 44)
p valu

Predialysis Ur (mg/dl)158 ± 59123 ± 48119 ± 44137 ± 102 ± 1489 ± 4NS
URR0.6 ± 0.10.6 ± 0.10.56 ± 0.10.68 ± 0.0.58 ± 0.0.62 ± 0.<.0001
Kt/V1.05 ± 0.051.06 ± 0.051.03 ± 0.051.23 ± 0.01.04 ± 0.051.18 ± 0.00,01
Cr (mg/dl)3.7 ± 1.42.8 ± 1.22.9 ± 1.13.6 ± 1.2.5 ± 2.4 ± 1.NS
K (mEq/L)4.7 ± 14.4 ± 0.94.3 ± 0.84.8 ± 4.3 ± 0.3.9 ± 0.0.04
P (mEq/L)6.5 ± 2.65.5 ± 2.15.8 ± 2.26 ± 2.5.5 ± 3.4.1 ± 1.0.009
Bic (mEq/L)18.3 ± 4.320.3 ± 420.3 ± 419.2 ± 4.20.9 ± 5.22.1 ± 3.NS
pH7.2 ± 0.18.4 ± 8.87.2 ± 0.097.2 ± 0.7.2 ± 0.7.2 ± 0.0.03
Presc. UF (ml)2064 ± 9272262 ± 8522217 ± 7552580 ± 1002626 ± 1122656 ± 1000.0002
Real UF (ml)1791 ± 9632032 ± 9301940 ± 9312345 ± 1012097 ± 1492240 ± 1290.0006
Real UF (ml/h)298 ± 160338 ± 156331 ± 149234 ± 98209 ± 147224 ± 1290.003
FB (1)3.27 ± 1.9-1.33 ± 2.63.47 ± 1.7-0.47 ± 2.4NS

Values are presented in mean and standard deviation.
PHD: prolonged hemodialysis, Ur: urea, URR: urea reduction ratio, Cr: creatinine, K: potassium, P: phosphorus, Bic: bicarbonate, UF: ultrafiltration, and Presc.: prescribed.
a: similar to S1 of G1, b: similar to S2 of G1, and c: similar to S3 of G1.
d: different from S1 of G1, e: different from S2 of G1, and f: different from S3 of G1.
NS: not significant (p >;0.05).